Funded Tech Companies
Sutro Biopharma
Looking for the VC firms that provided funding to Sutro Biopharma? Amgen Ventures, Lilly Ventures and Merck Capital Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Sutro Biopharma
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
310 Utah Ave. 150
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Sutro Biopharma, Inc. is a biopharmaceutical company that uses its patented OCFS protein synthesis technology to develop next-generation protein therapeutics for the treatment of human disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/30/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Newell
Chief Financial Officer
Edward Albini
Chief Medical Officer
Arturo Molina
Chief Scientific Officer
Trevor Hallam
Chief Technical Officer
Shabbir Anik
Vice President
Robert Kiss
Vice President
Mark Lupher
VP - Engineering
Henry Heinsohn
VP - Human Resources
Linda Fitzpatrick
VP - Operations
Nicki Vasquez
Company Investors
- Amgen Ventures
- Lilly Ventures (Armen Shanafelt)
- Merck Capital Ventures
- Celgene
- Tekla Capital Management
- Skyline Ventures (Leon Chen)
- Nexthera Capital
- SV Health Investors (Michael Ross)
- Samsara BioCapital
- Vida Ventures
- Alta Partners (David Mack)
- Eventide Asset Management
- Surveyor Capital
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs